Literature DB >> 566320

Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions.

V F Gellert, S G Holtzman.   

Abstract

Rats were housed on a cabinet designed to control their access to water or morphine solutions. They were trained to drink all of their fluid as morphine solutions or tap water during 5-minute access periods scheduled at 2 A.M., 8 A.M., 2 P.M. and 8 P.M. On this schedule, the morphine drinking rats consumed an average of 29, 27, 21 and 23% of their total daily fluid during the four respective access periods. The rats that had access to the 0.05% morphine solution drank an average of 53 mg/kg/day of morphine. Separate groups of rats were tested for morphine tolerance and dependence at 4-day intervals. Tolerance to the analgesic effect of challenge doses of morphine (3, 6 and 9 mg/kg) was first detected after 10 days of morphine drinking and reached a plateau after 18 days. Withdrawal scores for rats injected with 0.3 or 3 mg/kg of naloxone reached a plateau between 14 and 18 days of morphine drinking, whereas the scores of rats given 0.03 mg/kg were still increasing after 26 days of drinking. Plasma levels of morphine ranged between 167 and 300 ng/ml in blood samples collected 1 hour after each access period on the 18th day of morphine drinking. Six hours after the 8 A.M. access period, the levels of morphine in the plasma had decreased to 50% of the levels detected at 1 hour after the access period. Ninety percent of the rats accepted the morphine solutions and drank regularly for the 26 days the solutions were offered. They remained healthy throughout this period and, except for the fact that they gained 11% less body weight over the 26 days, they were visibly indistinguishable from the water drinking control rats.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 566320

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  74 in total

Review 1.  Paradoxical signal transduction in neurobiological systems.

Authors:  F C Colpaert; Y Frégnac
Journal:  Mol Neurobiol       Date:  2001 Aug-Dec       Impact factor: 5.590

2.  Functional interaction between opioid and cannabinoid receptors in drug self-administration.

Authors:  M Navarro; M R Carrera; W Fratta; O Valverde; G Cossu; L Fattore; J A Chowen; R Gomez; I del Arco; M A Villanua; R Maldonado; G F Koob; F Rodriguez de Fonseca
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

3.  Disrupting the memory of places induced by drugs of abuse weakens motivational withdrawal in a context-dependent manner.

Authors:  Stephen M Taubenfeld; Elizaveta V Muravieva; Ana Garcia-Osta; Cristina M Alberini
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-21       Impact factor: 11.205

4.  The effect of opioids on the development of postoperative intra-abdominal adhesions.

Authors:  Amir Khorram-Manesh; Jalal Vahedian Ardakani; Hamid Reza Behjati; Gunnar Nylund; Dick Delbro
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

5.  Discrete cues paired with naloxone-precipitated withdrawal from acute morphine dependence elicit conditioned withdrawal responses.

Authors:  Nurith Amitai; Jian Liu; Gery Schulteis
Journal:  Behav Pharmacol       Date:  2006-05       Impact factor: 2.293

6.  Modified 'Joyce model' of opioid dependence/withdrawal.

Authors:  Robert B Raffa; Ronald J Tallarida
Journal:  Eur J Pharmacol       Date:  2006-09-16       Impact factor: 4.432

7.  A new progressive ratio schedule for support of morphine self-administration in opiate dependent rats.

Authors:  Kenneth Grasing; Ning Li; Shaunteng He; Christopher Parrish; John Delich; John Glowa
Journal:  Psychopharmacology (Berl)       Date:  2003-05-06       Impact factor: 4.530

8.  Reduced emotional signs of opiate withdrawal in rats selectively bred for low (LoS) versus high (HiS) saccharin intake.

Authors:  Anna K Radke; Nathan A Holtz; Jonathan C Gewirtz; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2012-12-20       Impact factor: 4.530

9.  Dorsal hippocampal interleukin-1 signaling mediates heroin withdrawal-enhanced fear learning.

Authors:  Shveta V Parekh; Jacqueline E Paniccia; Christina L Lebonville; Donald T Lysle
Journal:  Psychopharmacology (Berl)       Date:  2020-08-28       Impact factor: 4.530

10.  Deletion of the type 2 metabotropic glutamate receptor increases heroin abuse vulnerability in transgenic rats.

Authors:  Jun-Tao Gao; Chloe J Jordan; Guo-Hua Bi; Yi He; Hong-Ju Yang; Eliot L Gardner; Zheng-Xiong Xi
Journal:  Neuropsychopharmacology       Date:  2018-10-03       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.